Amryt Pharma PLC (AIM:AMYT, NASDAQ:AMYT) announced its support for Global Epidermolysis Bullosa (EB) Awareness Week, which is taking place October 25 - 31, 2021.
Joe Wiley, Amryt’s chief executive, said: "Epidermolysis Bullosa is a very distressing condition which severely impacts the lives of those living with EB and also has a profound impact on parents, families and all those involved in their care.
“The current treatment paradigm focuses on wound care and dressing changes which can take several hours each day and can be extremely painful, often requiring the use of prescription pain medication.
“Our mission at Amryt is to transform the lives of people affected by rare, debilitating conditions by providing innovative medicines that bring hope to those in greatest need and if approved, we aim to bring the first approved treatment to the EB community in the near future.
“EB Awareness Week is a great opportunity to show our support for all those living with EB and to raise awareness of this truly horrendous condition."